Prunella vulgaris polysaccharide inhibits herpes simplex virus infection by blocking TLR-mediated NF-κB activation
Open Access
- 8 January 2024
- journal article
- research article
- Published by Springer Nature in Chinese Medicine
- Vol. 19 (1) , 1-16
Abstract
Background: Prunella vulgaris polysaccharide extracted by hot water and 30% ethanol precipitation (PVE30) was reported to possess potent antiviral effects against herpes simplex virus (HSV) infection. However, its anti-HSV mechanism has not yet been fully elucidated. Purpose: This study aimed to investigate the potential mechanisms of PVE30 against HSV infection. Methods: Antiviral activity was evaluated by a plaque reduction assay, and the EC50 value was calculated. Immunofluorescence staining and heparin bead pull-down assays confirmed the interactions between PVE30 and viral glycoproteins. Real-time PCR was conducted to determine the mRNA levels of viral genes, including UL54, UL29, UL27, UL44, and US6, and the proinflammatory cytokines IL-6 and TNF-α. The protein expression of viral proteins (ICP27, ICP8, gB, gC, and gD), the activity of the TLR-NF-κB signalling pathway, and necroptotic-associated proteins were evaluated by Western blotting. The proportion of necroptotic cells was determined by flow cytometric analysis. Results: The P. vulgaris polysaccharide PVE30 was shown to compete with heparan sulfate for interaction with HSV surface glycoprotein B and gC, thus strongly inhibiting HSV attachment to cells. In addition, PVE30 downregulated the expression of IE genes, which subsequently downregulated the expression of E and L viral gene products, and thus effectively restricted the yield of progeny virus. Further investigation confirmed that PVE30 inhibited TLR2 and TLR3 signalling, leading to the effective suppression of NF-κB activation and IL-6 and TNF-α expression levels, and blocked HSV-1-induced necroptosis by reducing HSV-1-induced phosphorylation of MLKL. Conclusion: Our results demonstrate that the P. vulgaris polysaccharide PVE30 is a potent anti-HSV agent that blocks TLR-mediated NF-κB activation. GraphicalKeywords
All Related Versions
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (82204437)
- Science and Technology Commission of Fengxian District, Shanghai Municipality (No. 22YF1445100)
- Key-Area Research and Development Program of Guangdong Province (No. 2020B1111110003)
This publication has 32 references indexed in Scilit:
- The Herpes Simplex Virus 1-Encoded Envelope Glycoprotein B Activates NF-κB through the Toll-Like Receptor 2 and MyD88/TRAF6-Dependent Signaling PathwayPLOS ONE, 2013
- Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry InhibitionFrontiers in Immunology, 2013
- Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathwayProceedings of the National Academy of Sciences, 2011
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune responseBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2006
- The herpes simplex virus ICP27 protein: a multifunctional post-transcriptional regulator of gene expressionBiochemical Society Transactions, 2005
- Herpes simplex virus gene products: the accessories reflect her lifestyle wellReviews in Medical Virology, 2004
- Herpes Simplex Virus Type 1 Induction of Persistent NF-κB Nuclear Translocation Increases the Efficiency of Virus ReplicationVirology, 1998
- Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein BJournal of General Virology, 1994
- Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.Journal of Cell Biology, 1992